Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Trial of Irinotecan (CPT-11) and Gemcitabine in Patients With Solid Tumors

NCT00004095 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT00004095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Trial of Irinotecan (CPT-11) and Gemcitabine in Patients With Solid Tumors
Lead sponsor
Northwestern University
Phase
Phase 1
Overall status
Completed
Start date
August 31, 1999
Completion date
October 31, 2008
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, breast cancer, colorectal cancer, kidney cancer, lung cancer, pancreatic cancer